SNRPC Human

Small Nuclear Ribonucleoprotein Polypeptide C Human Recombinant
Shipped with Ice Packs
In Stock

Description

Gene and Transcriptional Regulation

Genomic Context:

  • Gene Symbol: SNRPC (Entrez ID: 6631) .

  • Location: Chromosome 6p21.31 .

  • Function: Encodes a U1 snRNP-specific protein required for spliceosome assembly .

Alternative Splicing:

  • Produces non-coding transcript variants, though the primary isoform is protein-coding .

Role in pre-mRNA Splicing

SNRPC facilitates 5' splice site recognition by stabilizing U1 snRNA interactions with pre-mRNA. Key mechanisms include:

  • Spliceosome Activation: Participates in structural rearrangements during the transition from B to B^* spliceosomal complexes .

  • RNA Binding: Binds U1 snRNA via its zinc finger domain, ensuring fidelity in splice site selection .

Functional Network:

  • Associates with spliceosome components (e.g., PRP2, Sm proteins) and regulates ribonucleoprotein complex assembly .

Clinical Implications and Disease Associations

Oncogenic Role:

  • Hepatocellular Carcinoma (HCC): Overexpression correlates with advanced tumor stage, metastasis, and poor survival (HR = 2.1, P < 0.05) . Promotes epithelial-mesenchymal transition (EMT) via downregulation of E-cadherin and upregulation of Vimentin .

  • Non-Small Cell Lung Cancer (NSCLC): Drives tumorigenesis by regulating alternative splicing of RAB26, enhancing cell proliferation and colony formation .

Autoimmune Diseases:

  • Targeted by autoantibodies in systemic lupus erythematosus (SLE) and other connective tissue disorders .

Recombinant SNRPC in Research

Applications:

  • In Vitro Splicing Assays: Used to study spliceosome dynamics .

  • Antibody Production: Recombinant SNRPC serves as an antigen for autoimmune disease research .

Product Specs

Introduction
SNRPC, part of the U1 small nuclear ribonucleoprotein C family, is crucial for spliceosome formation. This protein component of the U1 small nuclear ribonucleoprotein (snRNP) particle is involved in nuclear precursor messenger RNA splicing. Autoantibodies, often found in patients with connective tissue diseases, target snRNP particles.
Description
Recombinant human SNRPC, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 182 amino acids (1-159 a.a.), including a 23 amino acid His-tag at the N-terminus, and has a molecular mass of 19.8 kDa. Note that the molecular weight on SDS-PAGE will appear higher. Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
A clear solution that has been sterilized by filtration.
Formulation
The SNRPC protein solution (0.25 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 50% glycerol, 0.3 M NaCl, 5 mM DTT, and 2 mM EDTA.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freeze the product at -20°C. It is advisable to add a carrier protein (0.1% HSA or BSA) for long-term storage. To maintain product integrity, avoid repeated freezing and thawing.
Purity
Purity is determined to be greater than 85% using SDS-PAGE analysis.
Synonyms
U1 small nuclear ribonucleoprotein C, U1 snRNP C, U1-C, U1C, SNRPC, Yhc1.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPKFYCD YCDTYLTHDS PSVRKTHCSG RKHKENVKDY YQKWMEEQAQ SLIDKTTAAF QQGKIPPTPF SAPPPAGAMI PPPPSLPGPP RPGMMPAPHM GGPPMMPMMG PPPPGMMPVG PAPGMRPPMG GHMPMMPGPP MMRPPARPMM VPTRPGMTRP DR.

Q&A

What is SNRPC and what is its primary function in human cells?

SNRPC, also known as U1-C or Yhc1, is a small nuclear ribonucleoprotein polypeptide that plays a crucial role in RNA processing. It functions as a component of the spliceosome complex and is involved in the recognition of the 5' splice site during pre-mRNA splicing. Functional network analysis has revealed that SNRPC is linked to the regulation of ribosome, spliceosome, and proteasome signaling pathways , indicating its fundamental importance in cellular processes.

Research methodologies for investigating SNRPC function include:

  • RNA interference using SNRPC shRNA lentiviral particles

  • Protein localization studies via immunohistochemistry

  • Interaction studies using co-immunoprecipitation techniques

How is SNRPC expressed across different human tissues and cancers?

SNRPC expression varies significantly across tissues, with particularly notable patterns in cancer tissues. According to the Human Protein Atlas data, SNRPC expression can be detected in multiple tissues with different expression intensity levels .

Table 1: SNRPC Expression Patterns in Normal vs. Cancer Tissues

Tissue TypeNormal ExpressionCancer ExpressionClinical Significance
LiverLowHighAssociated with poor prognosis in HCC
BrainVariableVariableRequires further investigation
BloodDetected-Potential biomarker applications

Methodologically, tissue expression analysis requires:

  • Validated antibodies for immunohistochemistry

  • RT-qPCR for mRNA quantification

  • Western blotting for protein level assessment

What evidence supports SNRPC's role in hepatocellular carcinoma (HCC)?

Extensive research has demonstrated that SNRPC is highly up-regulated in HCC tissues. In a cohort study of 224 HCC patients, immunohistochemistry assays revealed that SNRPC overexpression significantly correlated with:

  • Multiple tumors

  • Advanced disease stage

  • Poor clinical outcomes

Kaplan-Meier survival analysis confirmed that patients with high SNRPC expression exhibited shorter survival in four independent HCC cohorts (all P < 0.05). Furthermore, SNRPC mutations occur at significantly higher frequencies in HCC tissues compared to normal liver tissues and appear to be an early event in HCC development .

How does SNRPC affect tumor cell motility and epithelial-mesenchymal transition?

Gain- and loss-of-function experimental assays have demonstrated that SNRPC promotes the motility and epithelial-mesenchymal transition (EMT) of HCC cells in vitro . This provides mechanistic insight into how SNRPC might contribute to tumor progression and metastasis.

Methodological approach for investigating SNRPC in EMT:

  • Establish stable SNRPC knockdown and overexpression cell lines

  • Perform wound healing and transwell migration assays

  • Analyze EMT markers (E-cadherin, N-cadherin, vimentin) by Western blot

  • Validate findings with immunofluorescence staining

What is the relationship between SNRPC expression and tumor immune microenvironment?

Analysis using the TIMER (Tumor IMmune Estimation Resource) database has revealed that SNRPC expression negatively correlates with the infiltration of:

  • CD4+ T cells

  • Macrophage cells

  • Neutrophil cells

All correlations were statistically significant (P < 0.05), suggesting that SNRPC may play a role in modulating the immune response within the tumor microenvironment, potentially contributing to immune evasion mechanisms.

What single-subject research designs are most appropriate for studying SNRPC in rare disease contexts?

When investigating SNRPC in rare disease contexts, single-subject research designs offer several advantages:

Single-subject experimental designs deal effectively with individual effects and can be particularly valuable for studying rare conditions where large cohorts are unavailable . These approaches enable detailed distillation of both common and uncommon relevant factors across individuals through systematic replication.

The effectiveness of single-subject designs in SNRPC research stems from:

  • Ability to address important points of internal validity

  • Enabling inductive processes characteristic of quality early research

  • Powerful identification of generalizable processes that account for within-population diversity

Serial replications allow researchers to identify both common and unique patterns in SNRPC function across individuals, making this approach particularly valuable for translational research.

What approaches are available for inhibiting SNRPC expression in experimental models?

Several methodological approaches can be employed for SNRPC inhibition:

  • RNA interference:

    • SNRPC shRNA lentiviral particles are commercially available for inhibition of SNRPC expression in human cells

    • Requires appropriate control shRNA lentiviral particles

  • CRISPR-Cas9 gene editing:

    • Allows for complete knockout of SNRPC

    • Enables creation of stable cell lines for long-term studies

  • Antisense oligonucleotides:

    • Provides transient inhibition with potentially fewer off-target effects

    • Useful for time-course studies

When selecting an inhibition method, researchers should consider the specific research question, cell type sensitivity, and desired duration of inhibition.

How should multi-center human research projects on SNRPC be ethically coordinated?

Multi-center research on SNRPC should follow the National Mutual Acceptance (NMA) principles for single ethical review of multi-center human research projects:

  • Scientific and ethical review should be conducted by an NHMRC Certified Human Research Ethics Committee (HREC)

  • Research cannot commence at any site until authorization is provided by each participating site

  • The Principal Investigator is responsible for obtaining site authorization

The scope of NMA includes "any form of human research as defined in the National Statement on Ethical Conduct in Human Research 2007, for which an application must be made to a HREC for the purpose of being conducted at a public health organisation" .

This standardized approach ensures consistent ethical oversight while minimizing administrative burden across research sites.

What are the best practices for harmonizing SNRPC detection methods across different research centers?

To ensure comparability of results across research centers, standardization is essential:

Table 2: Recommended Standardization Approaches for Multi-Center SNRPC Studies

Research AspectStandardization RecommendationPurpose
AntibodiesUse same validated antibody clonesEnsure consistent detection
Sample ProcessingStandardized protocols for fixation/extractionMinimize technical variation
Data AnalysisShared analysis pipelinesFacilitate direct comparisons
Quality ControlRegular proficiency testingMaintain technical standards

Implementing these practices helps resolve potential discrepancies in SNRPC detection and functional assessment across different laboratories.

How can researchers use Google's 'People Also Ask' feature to enhance their SNRPC research?

Google's "People Also Ask" (PAA) feature provides researchers with valuable insights into knowledge gaps and related questions. For SNRPC research, this tool:

  • Reveals common questions related to SNRPC function and clinical relevance

  • Identifies related concepts that might not be immediately obvious

  • Suggests follow-up research questions that extend current understanding

The PAA box typically displays questions that either clarify the current search query or present follow-up questions that may interest users after finding initial answers . For SNRPC researchers, analyzing these questions can reveal:

  • Areas requiring more comprehensive investigation

  • Common misconceptions about SNRPC

  • Potential clinical applications not yet fully explored

What strategies optimize SNRPC content visibility in scientific communication?

To enhance the visibility and impact of SNRPC research, scientists should consider:

  • Address question-based knowledge gaps:

    • Structure research papers to answer questions commonly seen in 'People Also Ask' boxes

    • Include comprehensive FAQ sections in supplementary materials

  • Optimize content organization:

    • Use clear headings that align with common search queries

    • Present comparative data in tables rather than lists

    • Create concise abstracts that directly address primary research questions

How can researchers address contradictory findings about SNRPC function across different studies?

When confronted with contradictory findings regarding SNRPC function, researchers should implement a systematic approach:

  • Conduct methodological analysis:

    • Compare experimental models (cell lines vs. primary cultures vs. animal models)

    • Assess differences in SNRPC detection methods

    • Evaluate context-dependent effects in different tissues or disease states

  • Implement multi-method validation:

    • Use both gain- and loss-of-function approaches

    • Validate findings across multiple cell lines

    • Confirm key results with complementary techniques

  • Consider single-subject approaches:

    • Single-subject designs can help identify potential sources of variation

    • These approaches enable "detailed distillation of both common and uncommon relevant factors across individuals"

    • Serial replications can establish generalizability while accounting for variability

A hybrid approach combining both group experimental designs and single-subject methods provides the most comprehensive understanding of SNRPC function.

Product Science Overview

Gene and Protein Structure

The SNRPC gene is located on human chromosome 6p21.31 . It encodes a protein that is a specific component of the U1 snRNP particle. The U1 snRNP is one of the first snRNPs to interact with pre-mRNA, recognizing the 5’ splice site and facilitating the assembly of the spliceosome . The spliceosome is a complex molecular machine responsible for removing introns from pre-mRNA and ligating exons together.

Function and Mechanism

SNRPC is directly involved in the initial recognition of the 5’ splice site of pre-mRNA. This recognition is crucial for both constitutive and regulated alternative splicing . The interaction between SNRPC and the 5’ splice site precedes the base-pairing between the pre-mRNA and the U1 snRNA, ensuring accurate splicing and processing of mRNA .

Clinical Significance

SNRPC is not only essential for normal cellular function but also has clinical significance. Autoantibodies targeting snRNP particles, including SNRPC, are frequently produced by patients with connective tissue diseases . These autoantibodies can interfere with the normal function of snRNPs, leading to defects in mRNA splicing and contributing to disease pathology.

Research and Applications

Recombinant human SNRPC is used in various research applications to study the mechanisms of RNA splicing and the role of snRNPs in cellular processes. Understanding the function and regulation of SNRPC can provide insights into the molecular basis of diseases associated with splicing defects and aid in the development of therapeutic strategies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.